Arq, Inc.
ARQ Nasdaq Miscellaneous Chemical Products Financials FY2016βFY2025
What Arq, Inc. does
No business description yet.
- Legal name
- Arq, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 10, 2026
- Accession Β· CIK
- 0001515156-26-000021
0001515156
Revenue and margins
Arq, Inc. had $120M of revenue in fiscal 2025, up 10.4% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β$11.3M in fiscal 2025, β9.4% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Arq, Inc. returned β to shareholders in fiscal 2025. The diluted share count rose 15.2%.
Balance sheet
Cash, debt and the ratios that show how comfortably Arq, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $78.8M | $66.4M | $45.4M | $13.5M | $6.6M |
| Debt incl. finance leases | $7.3M | $9.2M | $26.5M | $26.4M | $29.0M |
| Net debt / EBITDA | β5.6x | β | β | 1.9x | β |
| Debt / equity | 0.0x | 0.0x | 0.1x | 0.1x | 0.2x |
| Interest coverage | 3.3x | β35.9x | β4.4x | β0.6x | β21.6x |
| Current ratio | 4.8x | 4.4x | 3.8x | 1.2x | 1.0x |
| Quick ratio | 4.4x | 3.7x | 2.9x | 0.7x | 0.7x |
| Total assets | $185M | $181M | $236M | $284M | $231M |
| Total liabilities | $38.1M | $41.2M | $57.1M | $67.1M | $62.6M |
| Shareholders' equity | $147M | $140M | $178M | $219M | $168M |
| Net debt (β = net cash) | β$71.4M | β$57.3M | β$18.9M | $12.8M | $22.4M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 4 / 8 | 2 / 8 | 6 / 8 | 6 / 8 | 6 / 8 | 3 / 8 | 0 / 8 | 5 / 9 | 2 / 9 |
| Accruals ratio | 108.1% | 41.7% | 37.4% | β16.0% | β46.4% | 20.7% | β1.6% | 2.1% | β6.0% | β19.4% |
| Altman Z'' | 1.17 | 9.85 | 1.56 | 2.53 | 1.17 | 8.90 | 7.59 | 5.66 | 4.31 | 1.53 |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $50.6M | $45.4M | $23.9M | $70.1M | $67.4M | $100M | $103M | $99.2M | $109M | $120M |
| Gross profit | β | β | β | β | β | β | β | $31.9M | $39.4M | $33.5M |
| Research and development | β$0.6M | $0.2M | β | $0.2M | $1.0M | $0.4M | $2.1M | $3.3M | $4.1M | $7.3M |
| Operating income | β$16.1M | β$4.1M | β$6.4M | β$14.9M | β$41.0M | $4.9M | β$12.1M | β$13.3M | β$2.0M | β$53.0M |
| Interest expense | $5.1M | $3.0M | $2.2M | $7.2M | $3.9M | $1.5M | $0.3M | $3.0M | $3.3M | $2.4M |
| Pretax income | $36.7M | $52.0M | $45.9M | $47.5M | β$13.8M | $76.1M | β$8.7M | β$12.1M | β$5.3M | β$52.6M |
| Income tax | β$60.9M | $24.2M | $10.4M | $12.0M | $6.5M | $15.7M | $0.2M | $0.2M | β$0.2M | $0.0M |
| Net income | $97.7M | $27.9M | $35.5M | $35.5M | β$20.3M | $60.4M | β$8.9M | β$12.2M | β$5.1M | β$52.6M |
| Net income to common | $96.6M | $27.7M | $35.3M | $35.5M | β$20.3M | β | β | β | β | β |
| Diluted EPS | $4.34 | $1.29 | $1.76 | $1.93 | β$1.12 | $3.27 | β$0.48 | β$0.42 | β$0.14 | β$1.27 |
| Diluted shares | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B | 0.03B | 0.04B | 0.04B |
| Cash flow | ||||||||||
| Cash from operations | β$18.3M | β$11.7M | β$9.9M | $62.3M | $54.0M | $26.0M | β$6.1M | β$16.7M | $10.5M | β$2.7M |
| Capital expenditure | $0.3M | $0.5M | $0.5M | $7.9M | $6.7M | $6.2M | $8.9M | $27.5M | $85.2M | $8.6M |
| Free cash flow | β$18.5M | β$12.2M | β$10.4M | $54.4M | $47.4M | $19.8M | β$15.0M | β$44.2M | β$74.7M | β$11.3M |
| Depreciation and amortization | $1.0M | $0.8M | $0.7M | $7.4M | $8.5M | $7.9M | $6.4M | $10.5M | $8.6M | $11.7M |
| Stock-based compensation | $2.9M | $2.2M | $2.5M | $2.0M | $2.5M | $1.9M | $2.0M | $2.6M | $2.7M | $3.4M |
| Acquisitions | $0.0M | $0.0M | $62.5M | $0.7M | $0.0M | β | β | β | β | β |
| Share buybacks | $0.0M | $16.4M | $25.3M | $5.8M | $0.2M | $0.0M | β | β | β | β |
| Dividends paid | $0.0M | $15.7M | $20.2M | $18.3M | $5.0M | $0.1M | $0.0M | $0.0M | β | β |
| Dividends and buybacks | $0.0M | $32.1M | $45.5M | $24.1M | $5.1M | $0.1M | $0.0M | $0.0M | β | β |
| Balance sheet | ||||||||||
| Cash and short-term investments | $13.2M | $30.7M | $18.6M | $12.1M | $35.9M | $78.8M | $66.4M | $45.4M | $13.5M | $6.6M |
| Total debt | $0.0M | $0.0M | $50.1M | $20.4M | $5.4M | $3.2M | $4.6M | $23.0M | $25.1M | $28.7M |
| Finance lease liabilities | β | β | β | $6.7M | $5.5M | $4.2M | $4.6M | $3.5M | $1.3M | $0.3M |
| Current assets | $38.9M | $36.9M | $59.8M | $47.0M | $62.0M | $108M | $106M | $86.5M | $52.4M | $43.9M |
| Current liabilities | $23.7M | $6.9M | $40.7M | $39.3M | $42.5M | $22.6M | $23.9M | $23.0M | $44.7M | $42.3M |
| Inventory | $0.0M | $0.1M | $21.8M | $15.5M | $9.9M | $7.9M | $17.8M | $19.7M | $19.3M | $15.9M |
| Property and equipment, net | $0.7M | $0.4M | $42.7M | $44.0M | β | β | β | β | β | β |
| Intangible assets | $0.7M | $0.8M | $4.8M | $4.2M | $2.0M | $1.2M | $0.8M | $7.9M | $7.6M | $0.6M |
| Total assets | $107M | $82.6M | $160M | $174M | $147M | $185M | $181M | $236M | $284M | $231M |
| Total liabilities | $31.1M | $9.2M | $91.7M | $65.5M | $61.5M | $38.1M | $41.2M | $57.1M | $67.1M | $62.6M |
| Preferred stock | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | $76.2M | $73.5M | $67.9M | $108M | $85.2M | $147M | $140M | $178M | $219M | $168M |
| Margins | ||||||||||
| Gross margin | β | β | β | β | β | β | β | 32.1% | 36.2% | 27.9% |
| Operating margin | β31.8% | β9.1% | β26.7% | β21.2% | β60.8% | 4.8% | β11.7% | β13.4% | β1.8% | β44.0% |
| EBITDA margin | β29.9% | β7.4% | β23.7% | β10.7% | β48.2% | 12.7% | β5.5% | β2.8% | 6.1% | β34.2% |
| Net margin | 193.0% | 61.4% | 148.1% | 50.7% | β30.1% | 60.2% | β8.7% | β12.3% | β4.7% | β43.7% |
| FCF margin | β36.6% | β27.0% | β43.2% | 77.6% | 70.3% | 19.7% | β14.5% | β44.5% | β68.6% | β9.4% |
| Returns | ||||||||||
| Return on capital | β25.6% | β6.3% | β5.0% | β9.5% | β59.2% | 5.4% | β12.2% | β6.8% | β0.7% | β22.0% |
| Return on capital employed | β19.3% | β5.5% | β5.4% | β11.1% | β39.4% | 3.0% | β7.7% | β6.3% | β0.8% | β28.1% |
| Return on equity | 128.2% | 37.3% | 50.1% | 40.3% | β21.0% | 52.0% | β6.2% | β7.7% | β2.6% | β27.2% |
| Return on assets | 91.0% | 29.4% | 29.3% | 21.3% | β12.7% | 36.4% | β4.9% | β5.9% | β2.0% | β20.4% |
| Return on tangible equity | 128.0% | 38.1% | 56.0% | 34.1% | β24.4% | 41.4% | β6.4% | β7.2% | β2.4% | β31.4% |
| Growth | ||||||||||
| Revenue growth | β | β10.4% | β47.2% | 192.7% | β3.9% | 48.9% | 2.7% | β3.7% | 9.9% | 10.4% |
| Net income growth | β | β71.5% | 27.2% | 0.2% | β157.1% | β | β114.8% | β | β | β |
| EPS growth | β | β70.3% | 36.4% | 9.7% | β158.0% | β | β114.7% | β | β | β |
| FCF growth | β | β | β | β | β13.0% | β58.2% | β175.6% | β | β | β |
| Share count change | β | β3.7% | β6.4% | β8.3% | β1.8% | 2.3% | β0.0% | 57.7% | 23.9% | 15.2% |
| Financial health | ||||||||||
| Net debt / EBITDA | β | β | β | β | β | β5.6x | β | β | 1.9x | β |
| Debt / equity | 0.0x | 0.0x | 0.7x | 0.2x | 0.1x | 0.0x | 0.0x | 0.1x | 0.1x | 0.2x |
| Interest coverage | β3.2x | β1.4x | β3.0x | β2.1x | β10.5x | 3.3x | β35.9x | β4.4x | β0.6x | β21.6x |
| Current ratio | 1.6x | 5.4x | 1.5x | 1.2x | 1.5x | 4.8x | 4.4x | 3.8x | 1.2x | 1.0x |
| Quick ratio | 1.6x | 5.4x | 0.9x | 0.8x | 1.2x | 4.4x | 3.7x | 2.9x | 0.7x | 0.7x |
| Capital allocation | ||||||||||
| Capex / revenue | 0.6% | 1.1% | 2.0% | 11.2% | 9.9% | 6.2% | 8.7% | 27.7% | 78.2% | 7.1% |
| Stock comp / revenue | 5.7% | 4.9% | 10.4% | 2.9% | 3.7% | 1.9% | 1.9% | 2.7% | 2.5% | 2.8% |
| Payouts / FCF | β | β | β | 44.2% | 10.8% | 0.5% | β | β | β | β |
| Quality scores | ||||||||||
| Piotroski F-score | β | 4.0 | 2.0 | 6.0 | 6.0 | 6.0 | 3.0 | 0.0 | 5.0 | 2.0 |
| Altman Z'' | 1.2 | 9.9 | 1.6 | 2.5 | 1.2 | 8.9 | 7.6 | 5.7 | 4.3 | 1.5 |
| Accruals ratio | 108.1% | 41.7% | 37.4% | β16.0% | β46.4% | 20.7% | β1.6% | 2.1% | β6.0% | β19.4% |
Source: SEC EDGAR XBRL filings (CIK 0001515156). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.